(4-(3,4-dihydroxyphenyl)-7,8 dihydroxy-2H-chromen-2-one)

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 新黄酮类化合物
• 英文名称: (4-(3,4-dihydroxyphenyl)-7,8 dihydroxy-2H-chromen-2-one)
• 英文别名: 7,8-dihydroxy-4-(3,4-dihydroxyphenyl)coumarin；7,8-Dihydroxy-4-(3',4'-dihydroxyphenyl)coumarin；4-(3,4-dihydroxyphenyl)-7,8-dihydroxychromen-2-one
• 化学式: C₁₅H₁₀O₆
• 分子量: 286.241
• InChiKey: RZBBRKRHUMTJTC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  107
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3,4-二甲氧基肉桂酸 在 氯化亚砜 、 溴 、 碘 、 氢化铝 、 potassium hydroxide 作用下， 以 乙醇 、 二氯甲烷 、 硝基苯 、 乙腈 为溶剂， 反应 11.33h， 生成 (4-(3,4-dihydroxyphenyl)-7,8 dihydroxy-2H-chromen-2-one)
  参考文献：
  名称：

  Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer’s disease agents

  摘要：

  Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.

  DOI：

  10.1016/j.bmcl.2019.126900

文献信息

• Synthesis and biological evaluation of novel neoflavonoid derivatives as potential antidiabetic agents
  作者：Bing Wang、Na Li、Teng Liu、Jie Sun、Xiaojing Wang

  DOI：10.1039/c7ra06457h

  日期：——

  Various substituted neoflavonoid derivatives were synthesized using sulfated montmorillonite K-10 as a catalyst. This method is environmental friendly, sustainable and economical, convenient in isolation and purification processes, with little byproducts, using earth-abundant catalysts and has relatively high yield. Those neoflavonoid derivatives were screened for antioxidant, a-glucosidase inhibitory

  使用硫酸化的蒙脱石K-10作为催化剂合成了各种取代的新类黄酮衍生物。该方法是环境友好的，可持续的和经济的，使用丰富的地球催化剂，在分离和纯化过程中方便，副产物少，副产物少。筛选那些新类黄酮衍生物的抗氧化剂，α-葡萄糖苷酶抑制作用，醛糖还原酶2（ALR2）抑制作用和晚期糖基化终产物形成抑制作用。大多数化合物显示出显着的抗氧化剂和先进的糖基化终产物（AGE）形成抑制活性。有趣的是，在30种化合物中，8k和8l被发现比标准药物槲皮素具有更高的ALR2抑制活性。药理研究表明，具有相邻7,8-二羟基基团的新黄酮类化合物在抑制ALR2方面更有效。抗糖尿病活性研究表明，化合物8l和8m在体内与标准药物glibenclamide等效。总之，目标化合物81提供了用于开发糖尿病和糖尿病并发症的治疗剂或预防剂的潜在药物设计概念。
• Synthesis of selected 3- and 4-arylcoumarin derivatives and evaluation as potent antioxidants
  作者：Ozkan Danis、Serap Demir、Cihan Gunduz、Mustafa Muhlis Alparslan、Selcuk Altun、Basak Yuce-Dursun

  DOI：10.1007/s11164-016-2445-7

  日期：2016.6

  radical scavenging, with better performance than known antioxidants in DPPH and metal-chelating assays. In addition, the cupric-reducing antioxidant capacity and ferric-reducing antioxidant power of the synthesized compounds were investigated for antioxidant activity. Among them, 5g , h and 6a , b showed significantly better Trolox equivalent antioxidant capacity (TEAC) than standard compounds. The results

  合成了一系列羟基，甲氧基和乙酰氧基取代的3-和4-芳基香豆素。筛选所有标题化合物的抗氧化能力，清除1,1-二苯基-1-吡啶并肼基（DPPH）自由基的能力以及螯合铁离子的能力。此外，使用分子特性预测评估所有衍生物，并使用Molinspiration评估药物相似性。结果发现，所有研究的衍生物均符合Lipinski关于药物相似性的5条规则，因此有可能进一步研究。在 邻位 具有两个羟基（例如 4h ， 5b ， h 和 6a）的 3-或4-芳香豆素 在自由基清除中具有显着的半最大有效浓度（EC 50），其性能优于已知的抗氧化剂。此外，研究了合成化合物的还原铜的抗氧化能力和还原铁的抗氧化能力。其中 5g ， h 和 6a ， b 与标准化合物相比，具有明显更好的Trolox等效抗氧化能力（TEAC）。结果表明，在芳族香豆素结构的苯并吡喃酮环的6-位和7-位具有二羟基的化合物是该系列中最活跃的抗氧化剂
• Synthesis and Anticancer Activity of 7,8-dihydroxy-4-arylcoumarins
  作者：Jianrui Wu、Ting Peng、Fang Chen、Yixin Leng、Linjiang Tong、Mengyuan Li、Rong Qu、Hua Xie、Jian Ding、Wenhu Duan

  DOI：10.2174/1570180812666141111235026

  日期：2015.3.24

  A series of 7,8-dihydroxy-4-arylcoumarins, the derivatives related to DW532 that was an anti-tumor agent targeting both kinase and tubulin, was prepared by Suzuki coupling reaction. Among them, compounds 6a, 6b, and 6c were found to exhibit anti-proliferation activities against human breast carcinoma MDA-MB-468 cells with IC50 values of 0.64, 0.69, and 1.33 μM, respectively and human epidermoid carcinoma A431 cells with IC50 values of 2.56, 1.78, and 2.29 μM, respectively. Further evaluation of the selected molecules revealed that they displayed broad-spectrum inhibitory activities against a panel of kinases including Flt-1, VEGFR2, RET, EGFR, etc. In vitro tubulin polymerization assay and molecular docking indicated that the substitution of 3’-OH and 4’-OCH3 on the 4-phenyl ring was essential to achieve potent tubulin inhibition.

  通过铃木偶联反应制备了一系列7,8-二羟基-4-芳基香豆素，它们是与DW532相关的衍生物，DW532是一种靶向激酶和微管蛋白的抗肿瘤药物。其中，化合物 6a、6b 和 6c 对人乳腺癌 MDA-MB-468 细胞具有抗增殖活性，IC50 值分别为 0.64、0.69 和 1.33 μM；对人表皮样癌 A431 细胞具有抗增殖活性，IC50 值分别为 2.对所选分子的进一步评估表明，它们对包括 Flt-1、血管内皮生长因子受体 2、RET、表皮生长因子受体等在内的一系列激酶具有广谱的抑制活性。体外微管蛋白聚合试验和分子对接表明，4-苯基环上 3'-OH 和 4'-OCH3 的取代是实现强效微管蛋白抑制的关键。
• Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer’s disease agents
  作者：Yinling Yun、Jie Yang、Yuhang Miao、Xiaojing Wang、Jie Sun

  DOI：10.1016/j.bmcl.2019.126900

  日期：2020.2

  Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.